文献速递儿科与产科急症心脑血管急症

N端脑钠肽前体与川崎病超急性期冠状动脉扩张的预测

N-terminal pro-brain natriuretic peptide and prediction of coronary artery dilatation in hyperacute phase of Kawasaki disease.
PubMed 文献 · Am J Emerg Med · 2018-06-08
一句话结论在儿科急诊川崎病超急性期(发热≤4天),血清NT-proBNP预测冠状动脉扩张的cutoff值为515.4 pg/ml,灵敏度78.26%、特异度61.63%,AUC 0.749。

本研究回顾性评估2010年1月至2014年12月儿科急诊就诊的1月龄至15岁川崎病超急性期(发热≤4天)患者,比较有和无冠状动脉扩张(CAD)者的血清NT-proBNP水平,CAD由超急性期24小时内经胸超声心动图判定。共纳入109例,其中23例在24小时内TTE发现CAD。CAD组NT-proBNP中位数824.1 pg/ml(IQR 515.4-1570.0)显著高于无CAD组396.4 pg/ml(IQR 184.8-767.8)(p≤0.001)。预测CAD的cutoff值为515.4 pg/ml,灵敏度78.26%、特异度61.63%,AUC 0.749(95%CI 0.642-0.856)。作者认为血清NT-proBNP可能作为儿科急诊川崎病超急性期早期检测CAD的附加实验室标志物。

要点

  • 川崎病超急性期(发热≤4天)CAD组血清NT-proBNP中位数824.1 pg/ml,显著高于无CAD组396.4 pg/ml(p≤0.001)。
  • 预测超急性期CAD的NT-proBNP cutoff值为515.4 pg/ml,灵敏度78.26%、特异度61.63%。
  • NT-proBNP预测超急性期CAD的AUC为0.749(95%CI 0.642-0.856)。
  • 研究为回顾性评估,109例中23例在超急性期24小时内TTE发现CAD。
  • 作者认为NT-proBNP可能作为儿科急诊川崎病超急性期早期检测CAD的附加实验室标志物。

适用人群与场景

  • 1月龄至15岁、在儿科急诊就诊的川崎病超急性期(发热≤4天)患者,且在超急性期24小时内接受经胸超声心动图检查。

诊断标准与关键阈值

  • 冠状动脉扩张(CAD)由超急性期24小时内经胸超声心动图判定。
  • 血清NT-proBNP预测超急性期CAD的cutoff值为515.4 pg/ml。

研究设计与关键结果

  • 研究类型:回顾性评估电子病历,时间2010年1月至2014年12月31日,纳入109例,其中23例在超急性期24小时内TTE发现CAD。
  • CAD组血清NT-proBNP中位数824.1 pg/ml(IQR 515.4-1570.0) vs 无CAD组396.4 pg/ml(IQR 184.8-767.8),p≤0.001。
  • NT-proBNP cutoff值515.4 pg/ml预测超急性期CAD,灵敏度78.26%、特异度61.63%。
  • NT-proBNP预测超急性期CAD的AUC为0.749(95%CI 0.642-0.856)。

证据类型、等级与局限

  • 证据类型:回顾性评估电子病历。
  • 作者结论:血清NT-proBNP可能作为儿科急诊川崎病超急性期早期检测CAD的附加实验室标志物。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为血清NT-proBNP可能作为儿科急诊川崎病超急性期(发热≤4天)早期检测CAD的附加实验室标志物。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Coronary artery dilatation (CAD) is a great concern with Kawasaki disease (KD). This study aimed to investigate the relationship between serum N-terminal pro-brain natriuretic peptide (NT-proBNP) levels and CAD in patients with the hyperacute phase (≤4 days of fever) of KD.

METHODS: Serum NT-proBNP levels were compared between patients with and those without CAD, who underwent transthoracic echocardiography (TTE) within 24 h of the hyperacute phase of KD in the pediatric emergency department (PED). Electronic medical records of patients aged 1 month to 15 years who visited the PED were retrospectively assessed from January 2010 to December 31, 2014.

RESULTS: One hundred nine patients were enrolled in the study. Twenty-three of those patients had CAD within 24 h of TTE. Median serum NT-proBNP levels were significantly higher in patients with CAD (824.1 pg/ml; interquartile range [IQR], 515.4-1570.0184.8-767.8 pg/ml) than in patients without CAD (396.4 pg/ml; IQR, 184.8-767.8 pg/ml) (p ≤ 0.001). The cutoff value of serum NT-proBNP, which predicted CAD during the hyperacute phase of KD, was 515.4 pg/ml, which yielded sensitivity of 78.26% and specificity of 61.63%. The area under the curve for NT-proBNP for predicting CAD during hyperacute KD was 0.749 (95% CI, 0.642-0.856).

CONCLUSION: Serum NT-proBNP might be an additional laboratory marker for detecting early CAD during the hyperacute phase of KD in the PED.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Jung JY, Ham EM, Kwon H, et al. N-terminal pro-brain natriuretic peptide and prediction of coronary artery dilatation in hyperacute phase of Kawasaki disease. Am J Emerg Med. 2018. PMID: 29903669. doi:10.1016/j.ajem.2018.06.021

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。